CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Affymax, Inc. Company Snapshot
Affymax, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Affymax with three other companies in this sector in UNITED STATES : Acer Therapeutics Inc (2013 sales of $1.27 million of which 100% was Cellular Therapies), Geron Corporation ($1.28 million of which 100% was Diagnostic Products), and Aveo Pharmaceuticals, Incorporation. ($1.29 million of which 100% was Cancer Therapeutics).

Sales Analysis. Sales levels dropped significantly in the second quarter of 2014 versus the previous year's second quarter. During the second quarter of 2014, sales at Affymax totalled $42,000.00 . This is a drop of 92.0% from the $525,000.00 in sales at the company during the second quarter in 2013. Sales fell dramatically in 2013: During the year ended December of 2013, sales at Affymax were $1.37 million. This is a sharp decrease of 98.5% versus 2012, when the company's sales were $94.37 million.
   
   
 
  Stock Performance Chart for Affymax, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): .06
(Figures in U.S. Dollars)
1 Week -1.6%   13 Weeks -29.4%  
4 Weeks -31.4%   52 Weeks 91.7%  
 
Affymax, Inc. Key Data:
  Ticker: AFFY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2013 Sales 1,369,000
(Year Ending Jan 2014).
Employees: 4
  Currency: U.S. Dollars Market Cap: 2,249,406
  Fiscal Yr Ends: December Shares Outstanding: 37,490,095
  Share Type: Common Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.